Natural killer (NK) cells have been defined as CD3e -,CD16 + and/or CD56 § lymphocytes that mediate major histocompatibility complex (MHC)-unrestricted cytotoxicity against certain tumors and virus-infected cells. Unlike T lymphocytes, NK cells do not rearrange or productively express T cell antigen receptor genes. Moreover, NK cells from adults have been reported to not express CD3% & or e proteins on the cell surface or in the cytoplasm. Nonetheless, NK cells have been shown to share a number of antigenic and functional similarities to T cells that suggest the possibility of common origins. In this report, we demonstrate that functional NK cells exist in liver at early stages of human embryonic development. Freshly isolated fetal NK cells mediated MHC-unrestricted cytotoxicity against NK-sensitive targets and acquired the ability to lyse NKresistant tumors after overnight culture in interleukin 2. Unlike adult NK cells, freshly isolated fetal liver NK cells and clones derived from these cells, as well as a subset of cord blood NK cells, express substantial levels of CD36 and CD3e proteins in the cytoplasm. Expression of CD3e and CD3~ transcripts and cytoplasmic proteins in fetal NK clones was confirmed by polymerase chain reaction and Western blot analysis. These findings support the concept that NK and T cells may arise from a common progenitor that expresses components of the CD3 complex. Alternatively, it is possible that the cytoplasmic CD36,e § fetal NK cells represent a distinct subpopulation of NK cells that is predominant in the fetus, but replaced by the cytoplasmic CD3~,e-adult NK cell population after embryogenesis.
N
'K cells I are a subpopulation of lymphocytes arising from bone marrow progenitor cells that are distinct from the progenitors of T and B cells (1) . NK cells have the capacity to kill certain tumors and virus-infected cells, but unlike CTL, do not require the presence of MHC class I or II antigens to recognize their targets. In addition to mediating cytolytic function, activated NK cells produce regulatory cytokines and growth factors, including IFN-% GM-CSF, and TNF-o~ (2) . The receptors on the membrane of NK cells that are responsible for recognition of tumors or virusinfected targets are presently unknown. NK cells do not rearrange TCR genes and do not express CD3E on the cell surface (3) (4) (5) (6) (7) (8) . Human NK cells can be identified by the phenotype membrane CD3e-(mCD3e) and CD16 § and/or CD56 + (9) . Mature NK cells have been reported to not ex-1 Throughout this article, the term NK cell will be used to designate lymphocytes with the antigenic phenotype (mCD3e-,CD56" ), which includes both CD16-and CD16 § NK cell subsets. press CD3y,/~,e proteins, but do express CD3~" in association with FcyRIII (CD16) (10, 11) .
Although TCR rearrangement clearly distinguishes mature NK and T lymphocytes, it is possible that these cells arise from a common progenitor before the rearrangement events that commit cells to the T lineage. While there has been extensive analysis of T lymphocyte development, particularly in the thymus, there has been essentially no information concerning NK cell ontogeny or differentiation. In this study, we have documented the existence and characteristics of functional NK cells present in human embryonic and fetal hematopoietic tissues.
Materials and Methods
Preparation of Lymphofftes. Embryonic and fetal tissues were obtained from elective therapeutic abortions. Gestation age was determined by crown-rump length and ranged from 6 to 24 wk. Mononuclear cells from fetal liver, spleen, and thymus were prepared by standard Ficoll-Hypaque procedures and cells suspended Monocytes and B cells were depleted by adherence to plastic and nylon wool, and large low buoyant density cells were isolated by centrifugation through discontinuous gradients of Percoll (Pharmacia Fine Chemicals, Piscataway, NJ), as previously described (12) .
mAbs. mAbs against the following antigens were used: CD1
(anti-Leu-6); CD2 (anti-Leu-Sb); CD3e (anti-Leu-4); CD3~5 CD3~ (mAb Sp64 [13] , generously provided by Dr. C. Terhorst, Harvard University, Boston, MA); TCR-3 (3F1; T Cell Sciences, Cambridge, MA); TCR-~5 (~-TCS1; T Cell Sciences); TCR-ot (c~F1; T Cell Sciences); (CD3~" (TIA-2 [14] , generously provided by Dr. P. Anderson, Dana Farber Cancer Institute, Boston, MA); CD4 (antiLeu-3a); CD5 (anti-Leu-1); CD6 (MB-G6, American Type Culture Collection [ATCC], Rockville, MD); CD7 (anti-Leu-9); CD8 (anti-Leu-2b); CD10 (anti-Calla); CDlla (L7); CDllb (anti-Leu-15); CDllc (anti-Leu-MS); CD14 (anti-Leu-M3); CD15 (anti-Leu M1); CD16 (anti-Leu-lla); CD18 (anti-LFA-l~); CD19 (antiLeu-12); CD25 (anti-IL-2R-cz, BD); CD33 (anti-Leu-Mg); CD34 (QBend/10. Immunofluorescence andFlow Cytometry. Cells were stained with fluorochrome-conjugated mAb for detection of cell surface antigens by immunofluorescence, as described (16) . Appropriate-purified or fluorochrome-conjugated isotype-matched control Igs were used in all experiments. Samples were analyzed using a FACScan* (Becton Dickinson & Co.). For detection of cytoplasmic CD3 and TCK proteins in fresh fetal NK cells, cells were first stained with an IgM isotype anti-CD56 mAb (clone L185), followed by a PE-conjugated rat antimouse IgM isotype-specific mAb. The cells were fixed for 10 min in ice-cold acetone, rehydrated for 20 min in PBS, and washed twice in wash buffer (PBS, pH 7.3, with 0.05% sodium azide and 2% FCS). Fixed cells were stained for 30 min with optimal amounts of purified mAb to detect cytoplasmic antigens, washed twice in wash buffer, and then stained for an additional 30 min with optimal amounts of FITC-conjugated antibodies specific for the isotypes of the mAbs used for the detection of the cytoplasmic antigens (anti-mouse IgG1 and anti-mouse IgG2).
For the detection of TdT, viable cells stained with PE anti-CD56 (as described above) were fixed for 30 min at 4~ in 1% paraformaldehyde PBS (pH 7.3) and then incubated an additional 5 min in 0.1% (final concentration) triton X-100 (Sigma Chemical Co., St. louis, MO). The fixed cells were washed twice in wash buffer and then stained with FITC-conjugated anti-terminal deoxynucleotidyl transferase (TdT) according to manufacturer's recommendations.
Purification of NK Cells. NK cells were isolated either by positive selection using FACS* or by negative depletion of other cell types using antibody-coated magnetic beads. For cell sorting experiments, cells were stained with a PE-conjugated anti-CD56 mAb and an FITC-conjugated anti-CD3e mAb, and mCD3e-,CD56 § lymphocytes were isolated to >98% purity using a FACStar Plus* flow cytometer (Becton Dickinson & Co.), as previously described (12) . For magnetic bead depletion, cells suspended in PBS containing 0.1% sodium azide were stained for 20 min on ice with saturating quantities of anti-CD3, CD4, CD5, CD14, CD19, CD33, CD71, and glycophorin A mAbs (all of which had been predetermined not to react with the cell surface of fetal NK cells). After staining, cells were washed extensively and combined with magnetic beads coated with sheep anti-mouse IgG (Dynal Inc., Great Neck, NY), according to manufacturer's recommendation.
NK cells were cloned at one cell per well using a single cell deposition system of the FACStar Plus* flow cytometer. Clones were established using culture conditions described previously (17) , and cloning efficiencies were generally 10-20%. All clones generated by this procedure were mCD3e-,CD56 + and mediated NK cytolytic function.
Cell-mediated Cytotoxicity. Cytotoxic activity was measured in a standard 4-h SlCr radioisotope release assay (18) . NK-sensitive targets assayed were K562 (erythroleukemia) and Jurkat (T leukemia). NK-resistant targets were Colo-205 (colon carcinoma), Colo-320 (colon carcinoma), JY (EBV-transformed B lymphoblastoid cell), SB (EBV-transformed B lymphoblastoid cell), Ramos (Burkitt's lymphoma), Arent (EBV-transformed B lymphoblastoid cell), Raji (Burkitt's lymphoma), and RMPI 8866 (myeloma). All tumor cell lines were obtained from ATCC, except Arent, which was generously provided by Dr. Ed Engleman (Stanford University). Antibody-redirected killing assays using the FCR-bearing mouse P815 tumor cell line were performed as previously described (19) .
PCR. RNA was isolated as described by Chirgwin et al. (20) , with minor modifications, eDNA was prepared in a 40-/~1 reaction volume containing 50 mM Tris-HC1, pH 8.3, 50 mM KC1, 10 mM MgC12, 1 mM DTT, 1 mM EDTA, 0.1 /xg/ml BSA, 1 mM dNTPs, 2 mM spermidine, 70 U KNAsin (Promega Biotec, Madison, WI), 0.4 mM Na pyrophosphate, 10 U AMV reverse transcriptase (Pharmacia Fine Chemicals, Piscataway, NJ), and 10 #g of total RNA. The reaction mixture was incubated at 42~ After 45 min, KNA was hydrolyzed by adding 40 #1 0.3 N NaOH and 30 mM EDTA, and boiling for 5 min. eDNA was phenol/chloroform extracted and ethanol precipitated. PCR were performed (43 cycles at 94~ for I min; 55~ for I rain; 72~ for I min) using a GeneAmp Kit (Perkin-Elmer Cetus, Norwalk, CT). Primers for PCK were: CD3e, 5'AGTTC~CG~AAGA.W~T-AATGAAGAAAY and 5'CCCAGGAAACAGC~AGTCGCAGG-GGGACTGGAGAG3'; CD3c5, 5'TGCAATACCAGCATCACATG-GGTAGAGGGAACGGT3' and 5'CTTGTTCCGAGCCCAGTTT-CCTCCAAGGTGC, CTGT3'; CD3% 5'AACCACTCCAAGTGT-ATTACAGAATGTGTCAGAAC3' and 5'ATICCTCCTCAACTGGTTTCCTTGAAGGq'GC~TGT3'; CD3~', 5'TGGAAC, GCGCT-TTTCACCGCGGCCATCCTGCAGGC3' and 5'GCGAGGC, C,G-CAGGC~CTC~ATGTGAA~GTCGT3'; CD4, 5'GCTGAT-GCTGAGCTTGAAACTGGAG3' and 5'GCTACATGTCTTCTG-AAACCGGTGAG3'; B2-microglobulin, 5'T TAAGCTTCTrTC-TGGCCTTGAGGCT3' and 5'TATTCTAGATGGAGCAACCTG-CTCAGA'3.
Southern Blot Analysis. Genomic DNA was isolated from NK clones, digested with restriction enzymes, transferred to nitrocel-lulose membranes, and hybridized with 32p-labeled DNA probes, as described (21) .
Iraraunotnecipitation and Western Blot Analysis. For Western blot
analysis, cells were washed in PBS and then lysed at 10 s ceUs/ml in Tris-buffered saline (TBS; 50 mM Tris, 150 mM NaC1, pH 8.0) containing 1% NP-40, 20 Kallikrein inhibitor U/ml aprotinin (Sigma Chemical Co.), and 1 mM PMSF (Sigma Chemical Co.) (22) . After incubation for 20 min on ice, nuclei were pelleted by centrifugation (13,000 g) for 5 min, and lysates were added to an equal volume of2x Laemmli sample buffer (23) containing 10% 2-ME. Samples were incubated in a boiling water bath for 5 min. 20/~1 of cell lysate containing 106 cell equivalents was subjected to dectrophoresis using 12% acrylamide gels (Bio-Rad Laboratoties, Richmond, CA) and transferred (100 V, 1 h) to Immobilon-P membranes (Millipore Continental Water Systems, Bedford, MA) using transfer buffer (25 mM Tris, 192 mM glyeine, 20% methanol). Membranes were incubated overnight at 4~ on a orbital shaker platform in 100 ml blot buffer (10 mM Tris, pH 8.0, 150 mM NaC1, 0.02% NAN3, 0.05% Tween-20) containing 5% nonfat dry milk. Membranes were then incubated in 25 ml blot buffer containing 5% nonfat dry milk and 5/~g/ml affinity purified rabbit anti-CD3e peptide antibody or 1/500 dilution of anti-CD38 mAb SP64 for 2 h at room temperature on an orbital shaker platform. After washing four times for 5 min in 100 ml blot buffer, membranes were incubated for I h at room temperature in 25 ml blot buffer containing 0.5/zCi/ml 12SI-labded protein A (for detection of rabbit antibody) or 0.2 /~Ci/ml 12SI-labeled sheep anti-mouse Ig (for detection of SP64 mAb) (Amersham Corp., Arlington Heights, IL). Membranes were washed four times for 5 min in 100 ml blot buffer, rinsed in distilhd water, and autoradiographed. Affinity-purified rabbit anti-CD3e peptide antibody was purchased from Dako (Denmark) and was generated against amino acids 156-168 (RKGHHLFPT(~MSP) in the cytoplasmic domain of human CD3e (24) .
Results

Ident~cation of NK Cells in Embryonic and Fetal T~sues.
Flow cytometric analysis was used to identify the presence and frequency of NK cells in embryonic and fetal tissues. Remarkably, a substantial proportion of the mononuclear cells isolated from livers of 6-24 wk gestation expressed the phenotype of adult NK cells (e.g., mCD3e-,CD56+). As early as 6 wk gestation, 5-8% of the total mononuclear cells were mCD3e-,CD56 +. Between 8 and 18 wk gestation, the total percentage of mCD3e-,CD56 + cells gradually increased to 15-25%. Representative data are presented in Fig. 1 A. It should be noted that while we have previously reported the presence of a small subset of mCD3e +,CD56 + T lymphocytes in adult blood (9), we never detected the presence of CD56 + T cells in any fetal tissues, mCD3e + ,CD56-T lymphocytes were initially observed in fetal liver at cord lymphocytes were NK cells, comparable with their frequency in adult blood. Moreover like adult NK cells, cord blood NK cells preferentially migrated with the low buoyant density cells on Percoll gradients where they comprise 35--60% of lymphocytes depending on the donor (Fig. 1 B) . At least three embryos or fetuses were examined for each gestational age shown. The total mononuclear cell population isolated from fetal livers consisted of enucleated erythrocytes and leukocytes, as well as other cell types of unknown origin. Therefore, to estimate the frequency of NK cells within the leukocyte population, we determined the frequency of NK cells within the population of cells expressing the common leukocyte antigen CD45. This was accomplished by simultaneous three-color immunofluorescence using PE-conjugated anti-CD56, FITCconjugated anti-CD3e, and peridinin chlorophyll protein (PerCp)-conjugated anti-CD45. By this analysis, NK cells comprised from 35 to 70% of the CD45-positive leukocytes in embryonic/fetal livers of 6-24 wk gestation (Fig. 2) . NK cells were also observed in fetal spleens between 15 and 24 wk gestation, where they comprised 15-30% of the CD45 + cells (Fig. 2 B) . NK cells were not readily observed in fetal thymus specimens between 16 and 24 wk gestation (Fig. 2 C) .
Freshly Isolated Fetal NK Cells Possess Spontaneous and IL,2-induced Cytolytic
Function. NK cells were purified from fetal liver (15-24 wk gestation), newborn cord blood, and adult peripheral blood by flow cytometry, and were assessed for cytolytic activity against NK-sensitive tumor cell targets (K562 and Jurkat) and an NK-resistant tumor cell target (Colo-205) in a 4-h radioisotope release assay. Freshly isolated fetal NK ceils demonstrated significant cytolytic activity against NKsensitive tumor cell targets (Fig. 3 A) . However, the level of cytotoxicity of fetal NK cells was lower than that observed for newborn or adult NK cells (Fig. 3 B) . In general, lytic activity of the purified liver NK cell populations increased with age of gestation.
Overnight incubation of fetal, newborn, or adult NK calls in rib2 (50 IU/ml) resulted in substantial augmentation of cytolytic activity (Fig. 3, C and D) . Fetal liver NK cells derived from 15 and 18 wk gestation did not demonstrate the magnitude of cytotoxicity observed for 24-wk gestation NK calls or newborn NK cdls, particularly against NK-resistant tumor cell targets.
Since a substantial percentage of fetal NK cells expressed CD16 (Fc3,RIII) at low levels on the cell surface (30-50% of total NK cells depending on the donor), assays were performed to determine if this molecule was competent to trigger cytolytic activity, mAbs against CD16 have been shown to initiate cytotoxicity against Fc receptor-bearing NK-resistant targets (19) . Purified fetal liver NK cells (18 wk gestation), newborn cord blood NK cells, and adult peripheral NK cells were combined with 51Cr-labeled murine P815 tumor cells precoated with either a nonreactive isotype control mAb, anti-CD16 mAb, or anti-CD56 mAb, and incubated for 4 h at 37~ Results from these experiments clearly showed that the CD16 molecule on fetal NK cells could efficiently signal cytotoxicity (Fig. 4) . The magnitude of cytotoxicity was less for fetal NK cells than that observed for either newborn or adult NK cell populations; however, this may be accounted for by the lower percentage of fetal NK cells expressing CD16.
Cytoplasmic Expression of CD3 Proteins.
Results from these studies have established that the freshly isolated mCD3e-, CD56 § lymphocyte population present in fetal hematopoietic tissues mediates spontaneous and IL-2-induced MHCunrestricted cytotoxicity against tumor cell targets and possesses ADCC function. Adult NK cells have been previously reported to express CD3~" protein in association with CD16 (11, 25) , but to lack membrane and cytoplasmic expression of CD3E proteins (26) . To compare fetal with adult NK cells, freshly isolated fetal liver, fetal spleen, newborn cord blood, and adult peripheral blood NK cells were stained with PEconjugated anti-CD56 mAb, fixed, and costained to detect the presence of cytoplasmic CD3 proteins. Consistent with previous studies, adult NK cells expressed cytoplasmic CD3~" protein and did not stain with anti-CD3e or anti-CD36 mAb (Fig. 5 C) . Surprisingly, the majority (50-80%) of fetal NK ceils showed prominent expression of CD3e, CD3/t, and CD3~" proteins (Fig. 5 A) . In the example shown in Fig. 5 , careful examination of the fluorescence histograms of fetal NK cells stained for cytoplasmic CD3e revealed that a small proportion ("~20%) lacked detectable CD3e, whereas the cytoplasmic CD3e-positive NK cells demonstrated two distinct levels of protein expression. Cytoplasmic CD3e proteins were detected in both the CD16-and CD16 + subsets of fetal NK cells (data not shown). The majority of fetal NK cells also expressed detectable levels of cytoplasmic CD3~ protein, in- (Fig. 5 B) . The percentage of newborn NK cells expressing CD3E and CD3~ was extremely variable from donor to donor. Using mAbs against CD3e and CD3~, we have never observed cytoplasmic CD3E or CD3~ in adult NK cells, mAb specific for CD33' were not available to determine expression of this subunit in freshly isolated fetal tissues. Cytoplasmic staining with mAbs against framework determinants of TCR-o~, TCR-B, and TCR-~ failed to reveal these proteins in either fetal or adult NK cells (data not shown).
To determine if the CD3 proteins were stably expressed in fetal NK cells, long-term (>4 too) clones of mCD3e-, CD56 + fetal liver NK cells were established using a FACS | single cell cloning system. Over 100 individual fetal NK cells clones were established and analyzed for cytolytic function, cell surface antigenic phenotype, and the expression of cyto-plasmic CD3 proteins. The majority of these clones (70%) expressed cytoplasmic CD3e, CD3~, and CD3~'proteins (Fig.  6 B) . Approximately 10% of the fetal NK cell clones expressed CD3E and CD3~', but no detectable CD3~. The remaining 20% of fetal NK clones expressed only CD3~" protein (Fig.  6 A) , which was characteristic of all adult peripheral blood NK cell clones. Both CD16-and CD16 + fetal NK cell clones have been generated, and cytoplasmic CD3e and ~ proteins are variably expressed in both types of NK cell clones (data not shown). Regardless of the expression of cytoplasmic CD3 proteins, all fetal NK clones were mCD3E-,CD56 + and demonstrated a very similar spectrum of cytolytic activity against a broad panel of tumor cell targets (two representative clones are presented in Fig. 7) . periments. CD33' transcripts were either absent or present in only very low levels in most fetal NK clones, including some clones that expressed high levels of cytoplasmic CD3e and CD35. However, CD33, transcripts were detected in certain fetal NK clones (e.g., NKBl.11). Representative fetal NK clones were analyzed for rearrangement of TCR-3 and TCR-y genes, and all were found to be in germline configuration (Fig. 9) .
Analysis of TCR
Western blot analysis was performed to confirm results from the PCR and immunofluorescence experiments. As shown in Fig. 10 , the presence of CD3e and CD3/i proteins of the appropriate molecular weight were detected in lysates of fetal NK clones NKB1.6, NKB1.13, NKB1.18, NKBl.11, and cord Fetal NK cells were assayed at an E/T ratio of 25:1, while newborn and adult NK E.'T was 12:1. NK cells were >95% pure based on reanalysis of the sorted NK cell populations. Figure 7 . Cytotoxic activity of fetal NK cell clones. Fetal NK cell clones described in Fig. 4 were assayed for cytotoxic activity against a broad panel of tumor cell targets in a 4-h slCr release assay. E/T was 3:1.
blood and adult PBL (enriched for NK cells). By placing an electronic gate on mCD3e-,CD56 + lymphocytes, it was shown that NK cells derived from fetal liver, cord blood, and adult peripheral blood displayed remarkable phenotypic similarities. NK cells, regardless of their source, did not express surface CD1, CD4, CD5, CD6, CD10, CD14, CD15, CD19, or CD45RO. Moreover, they did not express the hematopoietic progenitor antigen, CD34, nor did they express (TdT). Like adult NK cells, most fetal and cord blood NK cells expressed CD2, CD7, CD11a-c, CD18, CD38, CD45, and CD45RA, as well as the p75 IL2R (data not shown). Consistent with prior reports, CD57 was not found on fetal or cord blood NK cells (27) , but was detected on "~,50% of adult NK cells (18) . In contrast, the CD69 antigen, which has been characterized as an inducible lymphocyte activation antigen, was prominently expressed on all fetal NK cells and the majority of cord blood NK cells (Fig. 11) . Previously, we have reported that distinct subsets of adult peripheral blood NK cells can be identified based on the presence or absence of CD16 expression and the relative amount of CD56 (9, 28) . Interestingly, fetal and newborn NK cells generally expressed slightly higher surface density of the CD56 antigen than was observed on the majority of adult peripheral blood NK cells (Fig. 1) . Although CD16 was expressed on >90% of adult and newborn NK cells, fetal NK cells from either the liver or spleen generally expressed this antigen on "~30-50% of the cells (Fig. 11 A) . The CD16 antigen on fetal NK cells was present in low surface density compared with the high surface expression of this antigen on newborn and adult NK cells. Phenotypic analysis of cord blood lyre- cDNA was generated and expression of CD3e, CD3~, CD3'y, and CD4, and B2-microglobulin was assayed using appropriate primers. The arrow in each panel represents the expected size of the PCR product.
phocytes also revealed a significant population of mCD3e-lymphocytes that expressed CD16, but did not express detectable CD56 antigen (Fig. 11 B) . These cells were also identified in fetal liver between 16 and 24 wk gestation at very low frequencies (<1%). The relationship of these cells to NK cells is at present unknown and needs further investigation.
Discussion
The antigenic and functional properties of mature NK cells from adults have been extensively investigated. Based on these studies, it is believed that NK cells are distinct from B and T cells and likely represent a third lymphoid lineage (29) . However, the developmental relationship of B, T, and NK cells has not been delineated, and lymphoid progenitor cells have not been identified. Therefore, the primary objective of the present study was to carefully analyze the lymphoid populations of the developing human embryo and fetus for the presence of NK cells or possible NK progenitor populations. To our surprise, substantial numbers of NK cells were detected in all embryonic liver (6-9 wk gestation), fetal liver (9-23 wk gestation), fetal spleen, and cord blood populations studied. These NK cells were identified by the same criteria that have been used to define adult NK cells (e.g., mCD3e-,CD56 + lymphocytes), and like adult NK cells populations contained both CD16-and CD16 + subsets. By Figure 9 . Southern blot analysis of fetal NK clones. High molecular weight DNA was isolated from JY (B lymphoblastoid cell line; germline control) and a panel of fetal NK clones. 15/zg DNA from each was digested with the indicated restriction enzyme and fragments were subjected to electrophoresis through 1% agarose gels. Membranes were hybridized with radiolabeled C131 probe (41) or J71 PH60 (42) probes.
contrast with these peripheral lymphoid tissues, a substantial proportion of NK cells was not observed in fetal or neonatal thymus (<<1%). Moreover, we have shown that freshly isolated embryonic, fetal, and cord blood NK cells mediated MHC-unrestricted cytotoxicity against NK-sensitive tumors and acquired the ability to lyse NK-resistant tumors after overnight culture with IL-2.
The antigenic and functional properties of embryonic and fetal NK cells are very similar to a small subset of adult NK cells we have previously described based on the phenotype mCD3e-,CD56b~s ht (9, 28) . This population comprises <1% of PBL and was identified based on the observation that these cells expressed higher amounts of CD56 antigen and lower levels of CD16 than the majority of adult NK cells. Embryonic and fetal NK cells share a number of similarities Figure 10 . Western blot anal-)'sis of CD3 proteins. NP-40 detergent lysates were prepared from Ramos (Burkitt's lymphoma; negative control), Jurkat (T leukemia; positive control), and fetal liver NK clones. 106 cell equivalents of lysate were subjected to electrophoresis using 12% acrylamide gels and transferred to Immobilon membranes. Membranes were bbtted with affinity-purified rabbit anti-CD3e peptide antibody or mouse anti-human CD3~5 mAb SP64, as indicated. Bound antibody was detected using lzSI-labeled protein A or sheep anti-mouse Ig, respectively. Proteins of the predicted molecular weight of CD3e and CD3c5 are indicated by the arrow in each panel. Raji, another Burkitt's lymphoma used as a specificity control, was also negative (not shown).
with the CD56 bright NK cell subset in adult peripheral blood: (a) both express high surface density CD56 and lack or express only low levels of CD16; (b) neither express CD57; (c) both express high affinity IL-2Rs and respond to low concentrations of IL-2; and (d) both display lower constitutive cytolytic activity against NK-sensitive targets than the majority of circulating NK cells. We have previously proposed that the CD56b~ig ht NK cells may represent a more immature stage of NK cell differentiation (9, 28) . The numerous similarities between fetal NK cells and adult peripheral blood CD56 baght NK cells add support to this hypothesis; however, further studies are required to determine if they are related to a common differentiation pathway. However, an important distinction is that adult peripheral blood CD56bns h~ NK cells do not express cytoplasmic CD3e or CD3/~, but do express CD3~', as determined by immunofluorescent staining using mAbs against these structures (J. Phillips and L. Lanier, unpublished observation).
While prior studies on the existence and function of NK cells in the human fetus have been contradictory and of limited scope (30) (31) (32) , our present results clearly demonstrate that NK ceils arise very early during embryogenesis and that fetal NK cells are capable of both spontaneous MHC-unrestricted cytotoxicity and ADCC. Since maternal Ig can cross the placenta, NK cell-mediated ADCC may represent a significant immunological defense mechanism against viral and bacterial infections, before acquisition of T cell-mediated cellular immunity. While we have not as yet analyzed freshly isolated fetal NK cells for the capacity to produce cytokines, fetal NK clones do possess the ability to secrete IFN-% GM-CSF, and TNF-ot (H. Spits, T. Hori, and J. Phillips, unpublished observations). Thus, it is conceivable that NK cells provide a source of cytokines that may influence development and function of the fetal immune and hematopoietic systems. Due to the difficulty in obtaining human embryonic tissue before 6 wk gestation, we were unable to determine exactly when NK cells initially become detectable in the developing embryo. It is tempting to speculate that NK cells may initially arise from the primitive blood islands of the yolk sac during the very first wave of hematopoiesis.
Clearly the most unexpected feature of embryonic/fetal NK cells was the prominent expression of cytoplasmic CD3e and CD3/~ proteins. While CD3~" has been shown to coassociate with CD16 in NK cells (11, 25) , adult NK cells from both mice and humans have been reported to lack expression of other CD3 subunits (6, 26) . Moreover, although low levels of CD3~, but not CD3~ or CD3% mRNA have been identified in adult human NK clones, there has been no evidence for expression of CD3e protein in these cells (26) . Our present findings show that the majority of embryonic and fetal human NK cells and a small percentage of newborn cord blood NK cells express CD3e, CD3~, and CD3~'cytoplasmic antigens. We have confirmed the expression of CD3e and CD3~ in the fetal NK clones by immunofluorescence, PCR detection of transcripts, and Western blot analysis. Unfortunately, we were unable to directly assess the expression of CD33, antigen in fetal NK cells, since anti-CD33' reagents that could detect cytoplasmic protein by immunofluorescent staining were unavailable. However, PCR analysis revealed the presence of CD37 transcripts in some fetal NK clones, whereas CD33' mRNA was essentially undetectable in other clones. Preliminary studies using an anti-CD33, peptide antiserum for Western blot analysis failed to detect a mature CD33, glycoprotein in lysates prepared from fetal NK clones that expressed abundant CD3e and CD3~ cytoplasmic proteins (L. Lanier and J. Phillips, unpublished observations). However, further quantitative analysis of CD33~ mP, NA expression and a careful study using specific anti-CD33/antibodies is certainly required before it is appropriate to make any definitive conclusions.
The expression of CD3 subunits in fetal NK cells is an intriguing observation, particularly since the expression of cytoplasmic CD3e has been previously been used as an unambiguous marker to assign malignant and normal lymphocytes to the T lineage. It should be noted that all of the embryonic and fetal NK cells examined expressed CD7. Haynes et al. (33) have previously used immunohistochemical techniques to describe a population of lymphocytes in fetal liver and spleen with the phenotypes CD45 +, CD7 +, and cytoplasmic CD3e +. They have proposed that these cells represent pre-T cells that are committed to the T lineage and are destined for migration to the thymus. While some cells of this phenotype may be pre-T cells, our present finding would suggest that this population contains a substantial proportion of functionally competent NK cells that do not represent progenitors committed to the T cell lineage. Evidence in support of this hypothesis can be summarized as follows. (a) Most CD7 + ,CD45 + lymphocytes in fetal liver coexpress CD56. While CD56 can be expressed on a small subset of adult peripheral blood T cells (9), mCD36 § ,CD56 + T cells were essentially undetectable in all fetal tissues, including thymus. Moreover, mCD3-,CD7 + ,CD45 + thymocytes do not express CD56 (34 
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C ANTI-CD3 Figure 11 . Two-color antigenic phenotype of fetal, newborn, and adult NK cells. Mononuclear leukocytes from a 16 wk gestation fetal liver (A), low buoyant density lymphocytes from newborn cord blood (B), and low buoyant density lymphocytes from adult peripheral blood were analyzed by two-color immunofluorescence. In A, there were 20% NK cells (mCD3e-,CD56 +) and 10% T cells (mCD3E § ,CD56-). These NK cells did not express CD57, however, 50% expressed low surface density CD16, and 98% expressed CD69. In B, 40% of the low buoyant density cord blood lymphocytes were NK cells. Newborn cord blood NK cells did not express CD57; however, they expressed low density CD69 and high surface density CD16 on the majority of cells. In C, 45% of the adult peripheral blood low buoyant density cells were NK cells. In this donor, 70% of the NK cells expressed CD57, 98% expressed CD16, and <10% expressed low surface density CD69.
It seems unlike that undifferentiated progenitor cells would mediate these functions. (c) Fetal mCD3e-,CD56 + NK cells did not express the CD34, TdT, or HLA-DR+ proteins; all of which have been associated with progenitor populations (35) (36) (37) (38) and shown to be expressed on mCD3-,CD7 +, CD45 § thymocytes (34), (d) lqone of the long-term clones established from the mCD3e-,CD56 + fetal liver population acquired expression of TCR proteins or rearranged TCR genes. All maintained a stable NK antigenic phenotype and cytolytic function.
Collectively, these results caution against using expression of cytoplasmic CD3 proteins as definitive markers of the T cell lineage. However, these observations do support the possibility that NK and T lymphocytes arise from a common progenitor, before rearrangement of TCR genes in the T lineage. We propose that this hypothetical progenitor may reside in the fetal liver or adult bone marrow and give rise to (CD56-) cells that express cytoplasmic CD33,,5,e, and ~" proteins, before commitment to the NK or T lineage. As a consequence of as yet undefined signals, cells destined for the T lineage migrate to the thymus and initiate rearrangement of the TCR genes. By contrast, it is possible that progenitor cells not receiving these instructions or possibly responding to other stimuli downregulate expression of CD3c5, % and e and become committed to the NK lineage. If this hypothetical scheme is correct, CD33" may be downregulated first during commitment to the NK lineage, followed by loss of CD35 and CD3e proteins. In the majority of fetal NK ceils and in a minor subset of cord blood NK cells, expression of cytoplasmic CD3~5 and CD3e proteins persists, whereas both are apparently lost in the mature, adult NK populations in blood and spleen. An alternative possibility is that the cytoplasmic CD3~5,~ + fetal NK cells represent a distinct subpopulation of NK cells that is predominant in the fetus, but replaced by the cytoplasmic CD3/~,e-adult NK population after embryogenesis, comparable to the "waves" of y/5-TCR and ot/3-TCIL T cell populations that have been described during T cell development (39, 40) . The functional significance of CD3e and CD36 cytoplasmic proteins in fetal and cord blood NK cell is unknown. These may simply represent vestigial structures that are slowly eliminated as a consequence of maturation after the hypothetical NK/T cell progenitor has committed to the NK lineage.
